Immunostimulatory Properties of Dendritic Cells after Leishmania donovani Infection Using an In Vitro Model of Liver Microenvironment by Donaghy, Ludovic et al.
Immunostimulatory Properties of Dendritic Cells after
Leishmania donovani Infection Using an In Vitro Model
of Liver Microenvironment
Ludovic Donaghy
1,2., Florian Cabillic
1,3,4., Anne Corlu
1,5, Octavie Rostan
1,6, Olivier Toutirais
1,3,
Christiane Guguen-Guillouzo
1,5, Claude Guiguen
1,7, Jean-Pierre Gangneux
1,6,7*
1Universite ´ de Rennes 1, Rennes, France, 2Inserm U522, Re ´gulation des Equilibres Fonctionnels du Foie Normal et Pathologique, Rennes, France, 3EE 341 Biothe ´rapies
Innovantes, Rennes, France, 4Laboratoire de Cytoge ´ne ´tique et Biologie Cellulaire, CHU Rennes, Rennes, France, 5Inserm, UMR991, Liver Metabolisms and Cancer, Rennes,
France, 6EA SeRAIC 4427, IRSET, Rennes, France, 7Laboratoire de Parasitologie-Mycologie, CHU Rennes, Rennes, France
Abstract
Background: Recent advances demonstrated that liver dendritic cells (DCs) promote immunologic hyporesponsiveness that
may contribute to hepatic tolerance. Although there has been significant work on the phenotypic and functional roles of
such DCs, the impact of liver microenvironment on the immune properties of infected DC is still poorly explored, probably
because of the limitations of modelization.
Methodology/Principal Findings: Here, we hypothesized that DC tolerogenic properties have an impact on the
antimicrobial response, particularly during the infection by the protozoan parasite Leishmania donovani. Indeed, a
lymphocytic Th2 environment was reported to favour the growth and proliferation of L. donovani. We first modelized an
adequate monocyte-differentiated DC model, either in rat liver epithelial cell- or in a human hepatic non-parenchymal cell-
conditioned medium in order to infect them further. We established that DCs differentiated in a hepatic microenvironment
displayed a CD14+/CD16+/CD123+ phenotype, secreted low IL-12p70 and had an impaired capacity to stimulate allogeneic
T lymphocyte proliferation and IFNc secretion. We then infected DCs with L. donovani in the in vitro-defined hepatic
microenvironment. The infection of hepatic DCs restored their capacity to stimulate allogeneic T-cell proliferation and to
induce lymphocytic secretion of IFNc. Such characteristics were recently shown to favour granuloma formation in mice liver.
Conclusions/Significance: Our results suggest that the specific immunostimulatory properties of infected hepatic DCs
might amplify the granuloma maturation, which warrants the effective control of infection in the liver during visceral
leishmaniasis.
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Introduction
Parasitic infection with the obligate intracellular protozoan
Leishmania spp. results in a broad spectrum of clinical diseases in
humans. Visceral leishmaniasis (VL) is the most severe form of
leishmaniasis, compared to cutaneous, diffuse cutaneous and
mucocutaneous leishmaniasis. The viscerotropic species Leishmania
donovani and Leishmania infantum are responsible for 500,000 new
cases of VL each year in 62 endemic countries. VL ranges from
asymptomatic infection, known as the sub-clinical form, to acute
and potentially fatal disseminated disease with bone marrow, liver
and spleen involvement [1,2].
In the blood stream, freely circulating Leishmania parasites are
rapidly coated by complement molecules (C3, C5…) and
immunoglobulins. Complement receptors (CR1 and CR3) and
Fcc receptors expressed on macrophage and dendritic cell (DC)
membranes can recognize opsonized parasites and induce
phagocytosis [3,4]. In vitro infection of DCs with axenic non-
opsonized Leishmania has also indicated the involvment of the C
type lectin receptor DC-SIGN (dendritic cell-specific ICAM-3-
grabbing nonintegrin) in Leishmania internalization. DC-SIGN
mediated internalization acts by recognition of mannose glyco-
conjugates which are strongly expressed on the cytoplasmic
membrane of parasites [5,6]. However, its precise ligand has not
yet been described. DCs play a pivotal role in the control of
Leishmania infection by directing T-cell polarization and cytokine
production [3]. Their capability to modulate the immune response
greatly depends on parasite diversity, with contradictory data
obtained depending on whether DCs are infected with viscero-
tropic or dermotropic strains of Leishmania [7–15]. The response of
DCs to infection also depends on their lineage, stage of
maturation, processed antigens and tissue localization.
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exposed to a wide range of antigens. Pathogenic microorganisms
must be eliminated whereas a large number of dietary or
commensal organism antigens as well as hepatic metabolites must
be tolerated. Therefore, the liver has developed a specialized
immune system that favours tolerance rather than immunity
[16–22]. The survival of liver allografts without the need of
immunosuppressive treatment provides evidence of such tolerance
[23–25]. Thus, hepatic DCs may play a critical role in the accurate
initiation and control of the specialized immune response in the
liver [18,26]. Human liver myeloid DCs of human liver have been
identified in cells spontaneously migrating from thin pieces of liver
[27] and in cells eluted from donor livers prior to transplantation
[28]. Human liver myeloid DCs express a semi-mature phenotype,
with lower expression levels of CD80, CD86, DC-LAMP and
CCR7 than those of DCs in lymph nodes [28]. Hepatic DCs
express DC-SIGN, CD40 and MHC II molecules but also the
common monocyte lineage marker CD14 and the plasmacytoid
marker CD123 [27]. These cells synthesize IL-10 but not IL-
12p70 [18], whereas IL-12p40 and IL-12p35 transcripts were
detected by real-time PCR [27]. Finally, hepatic DCs stimulated T
lymphocytes to secrete IL-10 and very low amounts of IFNc [27].
One of our team has developed an in vitro model of monocyte-
derived DCs co-cultured with rat liver epithelial cells (RLEC). This
model of hepatic DCs differentiated into a CD11c
+/CD14
+/
CD123
+ DC subset that synthesized IL-10 but not IL-12p70 and
promoted a Th2 immune response [29]. Recently, Bamboat et al.
[30] definitely confirmed that human liver DCs promote
immunologic hyporesponsiveness through the generation of
suppressive T lymphocytes and a subset of IL-4 producing Th2
cells, via an IL-10-dependent mechanism.
In this study, we evaluated the molecular response of DCs to
Leishmania infection in a hepatic microenvironment. We first
developed an in vitro model for the differentiation of human
myeloid DCs in a hepatic microenvironment, using either a rat
liver epithelial cell-conditioned medium (RLEC-CM) or a human
hepatic non parenchymal cell-CM (hNPC-CM). We then
compared the molecular response of hepatic DCs to the infection
with a hepatotropic isolate of L. donovani. Here, we report that DCs
differentiated in a liver-CM show impaired allostimulating
capacity. The infection of these DCs with L. donovani amplified
their Th2 polarizing cytokine profile and restored their ability to
stimulate the proliferation and IFNc secretion of T lymphocytes.
This response could act as a specific hepatic immunological
mechanism involved in the control of parasitic infections.
Methods
Ethics statement
Access to the biopsy material was in agreement with French
laws and satisfied the requirements of the Ethics Committee of the
institution.
Cultures of hepatic cells and production of hepatic
conditioned medium
A rat liver epithelial cell line (RLEC) was isolated and cultured
in William’s E medium (Invitrogen, France) with 10% foetal calf
serum (FCS, Invitrogen) as described by Williams et al. [31].
Human hepatic cells were isolated from liver biopsies by
collagenase digestion [32] and centrifuged at low speed for
1 min. Hepatocytes were recovered from the pellet and the
enriched hepatic nonparenchymal cell (hNPC) population from
the supernatant. hNPCs were cultured in Williams’ E medium
with 10% FCS, 2 mM L-glutamine, 5 mg/mL bovine insulin,
5610
25 M hydrocortisone hemisuccinate. When RLEC or hNPC
reached confluence, the medium was removed and replaced with
RPMI 1640 Glutamax-I medium (Invitrogen, France) containing
10% FCS. The 24 h culture supernatant was then recovered,
filtered, and used as RLEC-CM and hNPC-CM for DC
differentiation.
Dendritic cell differentiation and maturation
Monocytes were isolated and purified from healthy blood
donor buffy-coats (Etablissement Franc ¸ais du Sang, Rennes,
France) using a RosetteSep
TM human monocyte enrichment
cocktail (StemCell Technologies, France) and centrifugation on
a Ficoll-Hypaque gradient (Sigma-Aldrich, St. Louis, Mo.).
Human monocytes were then plated (2610
6 cells in 2 mL) into
6-well culture plates. Monocytes were cultured in RLEC-CM or
hNPC-CM, both supplemented with IL-4 (500 U/mL; Pepro-
tech Inc., Rocky Hill, NJ). Control monocytes were simulta-
neously cultured in RPMI 1640 Glutamax-I medium containing
25 mM HEPES, 10% FCS, IL-4 (500 U/mL) and GM-CSF
( 8 0 0U / m L ;P e p r o t e c hI n c . ,R o c k yH i l l ,N J ) .O nd a y2 ,c u l t u r e s
were fed by removing half of the spent medium and adding fresh
medium containing cytokines to fulfill the initial volume of
2 mL. After 5 days of culture, immature myeloid DCs were
harvested and recultured (5610
5 cells/mL) for two additional
days in maturation medium containing complete culture
medium supplemented with IFNc (1000 IU/mL; Imukin,
Boehringer Ingelheim, France) and Escherichia coli LPS (1 mg/
mL; Sigma). Culture supernatant was recovered on day 7 and
centrifuged prior to be cryopreserved for subsequent analysis of
cytokine production. IL-10 and IL-12p70 secretions were
measured using ELISA kits (optEIA; BD Biosciences, France).
For the intracellular IL-12 detection, anti-IL-12 (p35/70p)-APC
antibodies from Miltenyi Biotec Inc. (USA) were used according
the manufacturer’s recommendations.
Parasite culture and DC infection
L. donovani strain MHOM/SD/97/LEM3427 Zym MON-18
was isolated from a patient with VL and was grown in vitro on
Author Summary
Because of its location and function, the liver is
continuously exposed to a wide range of antigens.
Pathogenic microorganisms must be eliminated while a
large number of dietary or commensal organism antigens
and hepatic metabolites must be tolerated. Therefore, the
liver has developed a specialized immune system that
favours tolerance rather than immunity and liver dendritic
cells (DCs) act as a major cell subtype in promoting this
response. Our work aimed to examine if such immunologic
hyporesponsiveness has an impact on the control of the
hepatic burden of Leishmania donovani, a protozoan
parasite that grows in liver and spleen tissues after
infection (called visceral leishmaniasis in South America
and Mediterranean basin, and Kala Azar in South East Asia).
We first modelized an original model of hepatic DCs and
infected them with Leishmania donovani. In contrast to
control DCs, infection of hepatic DCs restored the alterate
capacity of non-infected liver DCs to stimulate allogeneic T
cell proliferation and IFNc secretion. Such characteristics
were recently shown to favour granuloma formation in
mouse liver. This research provides an explanation for the
observation that Leishmania parasite growth is controlled
in the liver via an efficient granuloma response.
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carried out by culture in Schneider medium (Gibco, Invitrogen)
supplemented with 10% FCS and antibiotics (penicillin 200 IU
and streptomycin 200 mg/mL) for 6 days, until they reached
infective stationary phase. Five-day-old DCs were then exposed to
stationary phase promastigotes for 2 days. Carboxyfluorescein
diacetate succinimidyl ester (CFSE, Invitrogen, France) labelling of
Leishmania donovani promastigotes was performed at a 2 mM
concentration for 10
7 parasites/mL. Excreted-secreted antigens
(ESA) from Leishmania donovani were obtained by centrifugation of
the parasite suspension (600 g, 10 min) and 0,2 mm filtration of the
supernatant.
Flow cytometric analysis of cell surface molecules
Control and infected DCs were incubated for 30 min at 4uC
with monoclonal antibodies (mAb) directed against CD14, CD16,
CD40, CD86, HLA DR, CD123, DC-SIGN and CD83 (BD
PharMingen, USA) and CD1c (Miltenyi Biotec, France). Isotype-
matched control labelling was included in all experiments. For cell
viability assays, cells were incubated 5 min with 7ADD (e-
bioscience, SD, USA). Data acquisition was performed using a
FACSCalibur flow cytometer and CellQuest software (Becton-
Dickinson, USA). Data analyses were performed with WinMDI
software (J. Trotter).
Allogeneic stimulation assay
T lymphocytes were isolated from healthy blood donor buffy-
coats with RosetteSep
TM human T-cell enrichment cocktail
(StemCell Technologies, France) and centrifugation on Ficoll-
Hypaque gradient. Mixed leukocyte reactions (MLRs) were
carried out in 96-well culture plates with 200 mLo fm e d i u m .
Allogeneic lymphocytes (1610
5) were co-cultured in complete
RPMI 1640 medium with 7, 5 or 3-day-old DCs differentiated
either in RPMI 1640 medium or RLEC-CM and infected or not
with L. donovani. DC:T lymphocyte ratio of 1:10, 1:20 and 1:100
were used. Lymphocyte proliferation was measured on day 6
after a 16 h pulse with [
3H]-methyl-thymidine (1 mCi/well).
CD4+ or CD8+ T lymphocyte proliferation was characterized
by flow cytometry after CFSE labelling (0.2 mM concentration
for 10
6 cells/mL). To analyse cytokine production by lympho-
cytes, 1610
5 6-day-old MLR cultures lymphocytes were
restimulated with anti-CD3 (1 mg/mL) and anti-CD28 (1 mg/
mL) antibodies. IFNc,I L - 4a n dI L - 1 0s e c r e t i o nw a sm e a s u r e d
48 h after restimulation using ELISA kits (OptEIA, BD
Biosciences).
Statistical analysis
Statistical analyses were performed using the non-parametric
Mann-Whitney test. Values of p,0.05 were considered statistically
significant.
Figure 1. Immunophenotype and cytokine secretion profile of
monocyte-derived DCs from RLEC-CM and hNPC-CM cultures.
Monocytes were cultured in RPMI medium, RLEC-CM or hNPC-CM with
the indicated cytokine combinations. On day 5, DCs were harvested and
recultured (5610
5 cells/ml) for 2 days in the presence of IFNc (1000 IU/
ml) plus LPS (1 mg/ml). A. Cells were stained with specific antibodies
(thick line histograms) or isotype controls (thin line histograms). Results
for a single representative donor out of at least three donors are shown.
B. Production of IL-10 and IL-12p70 was measured by ELISA after 48 h
of maturation. Results are expressed as the mean 6 SD of at least three
experiments. When indicated, the mean value was statistically
significant compared to control DCs (*, p,0.05).
doi:10.1371/journal.pntd.0000703.g001
Figure 2. Allogeneic lymphocyte proliferation induced by DCs
from RLEC-CM culture. DCs were differentiated and matured (IFNc/
LPS) in RPMI medium in the presence of GM-CSF and IL-4, or in RLEC-CM
with IL-4 and then cultured for 6 days with allogeneic T lymphocytes
(1610
5). A. Lymphocyte proliferation induced by 3, 5 and 7-day-old DCs
was measured after a 16 h pulse with [
3H]-methylthymidine (1 mCi/
well); DC:T lymphocyte ratios of 1:10, 1:20 and 1:100 were used. *,
p,0.05; **, p,0.01; ***, p,0.001. B. T lymphocytes were labelled with
CFSE and stained with anti-CD4 and anti-CD8 antibodies for flow
cytometry analysis. Percentage of proliferating cells is indicated on the
histograms.
doi:10.1371/journal.pntd.0000703.g002
Leishmania donovani and Liver Dendritic Cells
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Hepatic conditioned-medium influences the
differentiation of monocytes in a specific hepatic DC
subset
The influence of the hepatic environment on human monocyte
differentiation was investigated using RLEC and hNPC condi-
tioned-medium (CM). Monocytes cultured in both RLEC-CM
and hNPC-CM differentiated into a CD16+/CD14+/CD123+
DC subset as shown in figure 1A. By contrast, control DCs were
CD16-/CD14-/CD123low. Over-expression of co-stimulatory
(CD40 and CD86) and MHC-class II molecules was observed
(data not shown) as previously shown using a co-culture model
[29]. Regarding the cytokine secretion, mature RLEC-CM- and
hNPC-CM-differentiated DCs produced IL-10 at similar level
than control DCs, but IL-12p70 secretion was dramatically
reduced compared with control DCs (p,0.05) (Fig. 1B). Thus,
both RLEC-CM and hNPC-CM DCs display the same specific
hepatic phenotype and secretion profile.
RLEC-CM DCs have an impaired capacity to stimulate
allogeneic T lymphocyte proliferation
To determine the capacity of this hepatic DC subset to induce
an immune response, we carried out MLRs. Allogeneic T
lymphocytes were co-cultured with 7, 5 ou 3 day-old DCs.
Thymidine incorporation assays demonstrated an impaired
capacity of RLEC-CM DCs to induce allogeneic lymphocyte
proliferation for both 1:10 and 1:20 DC:T lymphocyte ratios,
compared with control DCs (Fig. 2A). Flow cytometry analysis of
CFSE-labelled lymphocytes showed that the percentage of
proliferating T lymphocytes was two-fold lower with RLEC-CM
DCs than control DCs (13% vs 23% and 26% vs 48% for T CD4
and CD8, respectively). Moreover, the CD4:CD8 proliferating T
lymphocyte ratio was similar i.e. 1:2 for both RLEC-CM and
control DCs (Fig. 2B).
L. donovani infection does not alter the phenotypic
maturation of RLEC-CM DCs
To assess the effects of L. donovani infection on the immuno-
phenotype and cytology of RLEC-CM DCs, infection with L.
donovani was carried out during the final 2 days of DC culture. The
percentage of infected DCs ranged between 31% and 35% for
control DCs and was 49% and 48% for RLEC-CM DCs at days 1
and 3, respectively (Fig. 3A). The average of intracellular
amastigote number was of 3 per infected cells, either in RLEC-
CM and control DCs. This level of infection remained stable
between day 1 and day 3 suggesting their intracellular survival
(Fig. 3B and 3C). The viability of infected DCs was preserved as
shown by staining with the marker of cell viability 7AAD (Fig. 3D).
In addition, the infection of immature DCs did not induce the
CD83 maturation marker expression (Fig. 3E). By contrast, LPS
and IFNc maturation stimuli induced CD83 expression in non-
infected as well as in infected RLEC-CM and control DCs
(Fig. 3E). Of note that the use of CFSE-labelled parasites
evidenced that the up-regulation of CD83 was similar in the
infected cell and non infected cell populations (Fig. 3E). Moreover,
the immunophenotype (CD16, CD14, CD123, DC-SIGN, CD40,
CD86 and HLA-DR) of infected mature RLEC-CM and control
Figure 3. Infection of RLEC-CM and control DCs by L. donovani. Monocytes were cultured in RPMI or RLEC-CM with the indicated cytokine
combinations. On day 5, DCs were harvested and recultured (5610
5 cells/ml) for 2 days in the presence of IFNc (1000 IU/ml) plus LPS (1 mg/ml) with
or without L. donovani parasites (10:1). A/B. Percentage of infected cells and parasite number per infected cell: one and three day post-infection (dpi)
cells were analysed on May-Gru ¨nwald-Giemsa-stained cytospins. Data are the percentage of infected cell number/total cell number and the parasite
number per infected cells; data are mean 6 SD from three experiments; 250 cells were counted per experiment; NS=not significant difference. C.
Photographs of May-Gru ¨nwald-Giemsa-stained cytospins (arrows indicate intracellular parasites). D. Cell viability: cells were stained with 7ADD (thick
line histograms) or unstained (thin line histograms). Results for a single representative donor out of three donors are shown. E. CD83 expression: cells
were stained with anti-CD83 antibody (thick line histograms) or isotype control (thin line histograms). In some experiments, maturation was
performed one day post-infection (1 dpi maturation). When CFSE-stained L. donovani promastigotes (CFSE LD) were used, analysis of CD83 expression
was realized on CFSE-positive cells.
doi:10.1371/journal.pntd.0000703.g003
Leishmania donovani and Liver Dendritic Cells
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not shown).
L. donovani infection modifies the cytokine secretion
profile of mature RLEC-CM DCs
IL-10 and IL-12p70 secretion was measured in culture
supernatants of 7-day-old infected mature RLEC-CM and
control DCs. L. donovani infection did not modify control DC
secretion of IL-10 (Fig. 4A). Conversely, infection of RLEC-CM
DCs induced a statistically significant up-regulation of IL-10
secretion (p,0.01). IL-12p70 secretion was markedly higher in
non-infected mature control DC supernatants than in non-
infected RLEC-CM-differentiated DC supernatants. Infection of
both RLEC-CM and control DCs by L. donovani resulted in
significant decreased IL-12p70 levels (p,0.05) (Fig. 4A). IL-12
intracellular staining of DCs infected with CFSE-labelled
parasites or excreted-secreted antigens from parasites evidenced
that secretion ability was similarly reduced in infected and non-
infected cell populations (Fig. 4B).
L. donovani infection restores the allostimulating capacity
of mature RLEC-CM DCs
MLRs were carried out in order to determine the impact of L.
donovani infection on the capacity of RLEC-CM and control DCs
to stimulate allogeneic T lymphocyte proliferation and cytokine
secretion. L. donovani infection of control DCs did not modify
allogeneic lymphocyte proliferation (Fig. 5A). In contrast, infection
of mature RLEC-CM DCs significantly restored their capacity to
activate allogeneic lymphocyte proliferation (p,0.05). Regarding
the cytokine secretion, lymphocytes primed with mature RLEC-
CM DCs, and subsequently restimulated with anti-CD3 and anti-
CD28 mAbs, secreted significantly less IFNc than those primed
with control DCs (p,0.05) (Fig. 5B). The IFNc/IL-10 and IFNc/
IL-4 ratios from RLEC-CM DCs were lower than those of control
DCs (9 vs. 26 and 96 vs. 307, respectively). Interestingly,
lymphocytes stimulated with mature L. donovani infected RLEC-
CM DCs, as well as with mature infected control DCs, secreted
significantly higher amounts of IFNc compared to non-infected
DCs (p,0.01 and p,0.05, respectively) (Fig. 5B).
Discussion
The hepatic DC response to hepatotropic pathogens is still
poorly understood probably because only limited models of
hepatic DCs are available [18]. Human liver DCs have been
isolated and identified in cells eluted from donor livers prior to
transplantation [28] and in freshly purified cells from thin pieces of
liver [27,30]. Analyses of such ex vivo hepatic DCs revealed a semi-
mature phenotype [28] and expression of membrane markers
commonly associated with other lineages such as CD14 and
CD123 [27]. These liver DCs induced less alloproliferation and
promoted T cell hyporesponsiveness [30]. In vitro hepatic models
were also recently developed to generate human monocyte-
derived DCs in co-culture with either RLECs [29] or mouse liver
fibroblastic stromal cells [21]. Ex vivo and in vitro co-cultured
hepatic DCs failed to synthesize IL-12p70 and promoted a Th2
immune response orientation [18,21,27,29,30]. All together, these
results suggest that liver DCs have tolerogenic properties and put
into question the impact of such characteristics on the antimicro-
bial response.
Due to the presence of feeder cells [21,29] or a relatively low
purification levels [26], these models are not designed for infection
protocols. Cabillic et al. [29] suggested that hepatic characteristics
of DCs could be related to soluble molecules such as cytokines and
growth factors produced by the local environment. We then
developed a model of human monocyte-derived DCs in a hepatic
microenvironment without feeder cells using conditioned medium
from either hNPCs and RLEC. Here, we showed that DCs
generated in both hepatic cell-conditioned media share features
with control DCs, including typical morphology and expression of
DC-SIGN as well as over-expression of MHC II (HLA-DR) and
co-stimulation molecules (CD40, CD86), compared to monocytes.
DCs differentiated in hNPC- and RLEC-CM display a similar
immunophenotype defined as a CD14+/CD123+ DC subset, in
accordance with previous studies using other experimental models
[27,29,33]. Furthermore, we showed that CD123 expression was
increased during maturation of these cells and that they also
expressed CD16. Mature control DCs secreted IL-10 and IL-
12p70 and activated allogeneic lymphocyte proliferation. Con-
trastingly, DCs differentiated in both hepatic microenvironments
secreted very low amounts of IL-12p70, were poor inducers of
lymphocyte proliferation, as described ex vivo by Goddard et al.
[27]. In accordance with ex vivo [27,30,34,35] and in vitro [21,29]
studies, our results confirm that liver constitutes a specific micro-
Figure 4. Cytokine secretion profile of DCs after L. donovani
infection. Monocytes were cultured in RPMI medium or RLEC-CM with
the indicated cytokine combinations. On day 5, DCs were harvested and
recultured (5610
5 cells/mL) for 2 days with IFNc (1000 IU/mL) plus LPS
(1 mg/mL). A. L. donovani infection was carried out at a ratio of 10:1
(parasites:DCs). Secretion of IL-10 and IL-12p70 was measured in the
culture supernatant by ELISA after 48 h. Results are expressed as the
mean 6 SD of at least three experiments. When indicated, the mean
value was statistically significant compared to non infected DCs (*,
p,0.05; **, p,0.01). B. Infection was carried out with CFSE-labelled
parasites or excreted-secreted antigens (ESA) from L. donovani.
Intracellular staining of IL-12 was evaluated by flow cytometry analysis.
Percentage of IL-12 positive-cells among the whole cell population or
among infected cells (CFSE+) and non infected cells (CFSE-) is indicated
on the cytograms.
doi:10.1371/journal.pntd.0000703.g004
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DCs.
We then analysed the molecular response of this DC subset to
parasitic infection. Because primary human hNPCs were isolated
from human liver biopsies, it was easier to use an in vitro model
with RLEC-CM for infection protocols. We selected the
hepatotropic protozoan L. donovani and examined the impact of
an hepatic microenvironment on DC response to infection.
Whereas recent studies with dermotropic Leishmania strains
highlighted the importance of a dermal cytokine microenviron-
ment for initiation of a local inflammatory response [36], no data
are available concerning the liver, one of the main target organ
during VL. Here we showed that L. donovani infection did not
induce the maturation of DCs when infecting either immature
DCs differentiated in control medium or in RLEC-CM. Indeed,
we neither observed CD83 expression nor over-expression of co-
stimulatory molecules CD40 and CD86 or HLA-DR, and there
was no induction of IL-12p70 secretion (data not shown). Our
results are in agreement with those obtained with L. mexicana and
L. amazonensis suggesting that the promastigote surface is devoid of
DC-activating signals and that DCs infected with stationary-phase
promastigotes remain phenotypically immature [8,13]. In addi-
tion, we showed that L. donovani parasite did not further inhibit the
maturation process of infected DCs (i.e., over-expression of co-
stimulatory molecules and MHC II, expression of CD83 and
morphological modifications). However, in contrast with the
findings from McDowell et al. [11], we observed a strong inhibition
of IL-12p70 secretion during infection of mature RLEC-CM and
control DCs.
In our experimental model, L. donovani infection increased the
IL-10 secretion of DCs differentiated in RLEC-CM. Thus,
infected hepatic DCs may be partly responsible for the high
serum IL-10 levels observed in patients with active VL [37,38].
Furthermore, L. donovani infection of DCs differentiated in RLEC-
CM restored their impaired capacity to stimulate allogeneic
lymphocyte proliferation and up-regulated lymphocyte IFNc
secretion. A similar simultaneous co-expression of IL-10 and
IFNc is detected in the serum of acute VL patients [37,38].
Furthermore, a Leishmania-specific subtype of CD4+ lymphocytes
from individuals cured of VL has even been described as IFNc+/
IL-10+ [39]. In this context, Amprey et al. [40] have described a
liver-specific secretion of IFNc a few hours after Leishmania
infection. This secretion was independent of IL-12p70 and was
suggested to be produced by a subset of NKT cells.
In the liver, parasites are phagocytosed by Ku ¨pffer cells and
DCs. Infected cells secrete cytokines and recruit lymphocyte sub-
populations in order to create a granuloma. A well-formed mature
granuloma is an antigen-specific immune response mediated by
mononuclear cells. Such mature granuloma presents a delayed
appearance but a long-term persistence. During human VL,
mature hepatic granulomas commonly correlate with infection
control and clinical latency [41]. Cytokines such as IFNc and
TNFa are involved in the activation of immunocompetent cells
and account for the final microbicidal response [1,41]. However,
variable responses can be observed, depending on the host’s
genetic and immunological environment. Using a non-infected
model of IL-1 receptor antagonist-deficient mice, impaired DC
maturation associated with IL-10 secretion was shown to
exacerbate granuloma formation in murine liver [42]. Moreover,
the transfer of liver DCs loaded with an antigen to the portal vein
of mice was shown to induce a Th2 orientation of immune
response [43]. During Schistosoma mansoni/L. donovani co-infection,
Hassan et al. [44] similarly demonstrated that mature hepatic
granuloma formation was favoured by the Th2 cytokine
environment induced by S. mansoni infection. All together, an
efficient granuloma response in a Th2 environment may
Figure 5. Proliferation and cytokine secretion of allogeneic lymphocytes stimulated with DCs after L. donovani infection. DCs were
differentiated and matured (IFNc/LPS) in RPMI medium in the presence of GM-CSF and IL-4, or in RLEC-CM with IL-4. Five-day-old DCs were infected
or not with L. donovani (10:1). Allogeneic lymphocytes (1610
5) were co-cultured with 7-day-old mature infected or non-infected DCs (5610
3). A.
Lymphocyte proliferation was measured on day 6 after a 16 h pulse with [
3H]-methylthymidine (1 mCi/well). B. Lymphocytes were collected after 6
days of stimulation, washed and restimulated for 48 h with anti-CD3 and anti-CD28 mAbs. Supernatants were harvested and analysed by ELISA for IL-
4, IL-10 and IFNc secretion. Results are expressed as the mean 6 SD and represent at least three experiments. When indicated, the mean value is
statistically significant compared to non-infected DCs (*, p,0.05; **, p,0.01).
doi:10.1371/journal.pntd.0000703.g005
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a major cell subtype involved in the induction and maintenance of
such Th2 environment. This newly described in situ activation of
the liver immune response might represent a complementary
phenomenon with the model proposed by Engwerda et al. [45,46],
in which lymphocytes are primed in the spleen, where IL-12p70
production is important, and then migrate to the liver. Our data
show that L. donovani infection of DCs within a hepatic
environment restores their ability to induce allogeneic lymphocyte
proliferation and IFNc secretion. Such results suggest the existence
of an intrinsic liver activation pathway that could contribute to
granuloma formation, in addition to the spleen-mediated activa-
tion way described previously.
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